Your browser doesn't support javascript.
loading
CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells.
Piercy, Jenny; Petrova, Svetla; Tchilian, Elma Z; Beverley, Peter C L.
Afiliação
  • Piercy J; The Edward Jenner Institute for Vaccine Research, Compton, Berkshire RG20 7NN, UK.
Immunology ; 118(2): 250-6, 2006 Jun.
Article em En | MEDLINE | ID: mdl-16771860
ABSTRACT
CD45 is known to regulate signalling through many different surface receptors in diverse haemopoietic cell types. Here we report for the first time that CD45-/- bone marrow dendritic cells (BMDC) are more activated than CD45+/+ cells and that tumour necrosis factor (TNF) and interleukin-6 (IL-6) production by BMDC and splenic dendritic cells (sDC), is increased following stimulation via Toll-like receptor (TLR)3 and TLR9. Nuclear factor-kappaB activation, an important downstream consequence of TLR3 and TLR9 signalling, is also increased in CD45-/- BMDC. BMDC of CD45-/- mice also produce more TNF and IL-6 following stimulation with the cytokines TNF and interferon-alpha. These results show that TLR signalling is increased in CD45-/- dendritic cells and imply that CD45 is a negative regulator of TLR and cytokine receptor signalling in dendritic cells.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Interleucina-6 / Fator de Necrose Tumoral alfa / Antígenos Comuns de Leucócito Limite: Animals Idioma: En Ano de publicação: 2006 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Interleucina-6 / Fator de Necrose Tumoral alfa / Antígenos Comuns de Leucócito Limite: Animals Idioma: En Ano de publicação: 2006 Tipo de documento: Article